Mst. Mahfuza Rahman, Md. Kouser, Uthpall Kumar Roy, Shahriar Mohammad Shohan, Md. Jahirul Islam, Mst. Shagorika Shila, Sangita Chakraborty, Mir Imam Ibne Wahed
Mst. Mahfuza Rahman1*, Md. Kouser1, Uthpall Kumar Roy1, Shahriar Mohammad Shohan1, Md. Jahirul Islam1, Mst. Shagorika Shila1, Sangita Chakraborty1, Mir Imam Ibne Wahed2
1Department of Pharmacy, Comilla University, Koatbari, Cumilla - 3506, Bangladesh.
2Department of Pharmacy, University of Rajshahi, Rajshahi - 6205, Bangladesh.
Volume - 16,
Issue - 5,
Year - 2023
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a worldwide health hazard that has been classified as a pandemic by the World Health Organization (WHO). The task of developing efficient prevention and treatment measures for this pandemic is unparalleled. Due to nano-material's unique physicochemical features and controlled nano-bio interactions, nanotechnology has demonstrated significant potential in its capacity to combat a number of healthcare conditions. The application of nanotechnology for COVID-19 has been discussed in depth in this systematic review, which is divided into three sections: prevention, diagnostics, and treatment. To begin, we focused on nanotechnology-based protective equipment and disinfectants that can give much-needed protection against SARS-CoV-2. Again, nanoparticles can be used as an antigen carrier or adjuvant, paving the path for the development of a number of vaccines with preventive benefits. The capacity of nano-materials to magnify signal is then highlighted, which has been employed in the development of nano-biosensors and nano-imaging techniques that can be used for early-stage detection in conjunction with other diagnostic instruments. Finally, we discuss COVID-19 therapeutic approaches based on nano-materials. Nano-metals and their oxides affect cellular processes by interfering with the production of reactive oxygen species (ROS), which then give antiviral action. Various nano-products (polyethylenimine, squalene) can significantly lower the synthesis of inflammatory modulators (Cytokine storm), hence preventing Covid-19 infection. The review's limitations and nanoparticle's future directions for COVID-19 have been described briefly. This review is quite comprehensive and useful in terms of providing suggestions for developing nanomaterial-based devices to combat against COVID-19.
Cite this article:
Mst. Mahfuza Rahman, Md. Kouser, Uthpall Kumar Roy, Shahriar Mohammad Shohan, Md. Jahirul Islam, Mst. Shagorika Shila, Sangita Chakraborty, Mir Imam Ibne Wahed. The Significance and Implications of Nanotechnology in COVID-19. Research Journal of Pharmacy and Technology 2023; 16(5):2409-6. doi: 10.52711/0974-360X.2023.00411
Mst. Mahfuza Rahman, Md. Kouser, Uthpall Kumar Roy, Shahriar Mohammad Shohan, Md. Jahirul Islam, Mst. Shagorika Shila, Sangita Chakraborty, Mir Imam Ibne Wahed. The Significance and Implications of Nanotechnology in COVID-19. Research Journal of Pharmacy and Technology 2023; 16(5):2409-6. doi: 10.52711/0974-360X.2023.00411 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-5-70
1. Talele SG, Ahire ED, Surana KR, Sonawane VN, Talele GS. Corona Virus Disease (COVID-19): A past and Present Prospective. Asian Journal of Pharmaceutical Research. 2022 Mar 5;12(1):45-53.
2. Vishnu KN, Uppala PK, Vangoori Y, Gudhanti SN. A Review on Covid 19 Pandemic and its Global Effects. Asian Journal of Pharmaceutical Research. 2021 Dec 1;11(4).
3. Cevik M, Kuppalli K, Kindrachuk J, et al. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020; 371: m3862.https://doi.org/10.1136/bmj.m3862
4. Naresh BV. A review of the 2019 novel coronavirus (covid-19) pandemic. Asian Journal of Pharmaceutical Research. 2020;10(3):233-8.
5. Hamid S, Mir MY, Rohela GK, et al. Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics). New Microbes and New Infections. 2020; 35: 100679. https://doi.org/10.1016/j.nmni.2020.100679
6. Negi R, Saharan K, Pillai K. Knowledge regarding Immunity Boosting Measures for Self-care during COVID-19 crisis: Survey of Urban Community in Haryana. Asian Journal of Nursing Education and Research. 2021 Oct 1;11(4):488-94.
7. GeurtsvanKessel CH, Okba N, Igloi Z, et al. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment. Nature Communications. 2020; 11(1): 1-5. https://doi.org/10.1038/s41467-020-17317-y
8. Yadav AR, Mohite SK. A Novel approach for treatment of COVID-19 with Convalescent plasma. Research Journal of Pharmaceutical Dosage Forms and Technology. 2020;12(3):227-30.
9. Choi JR. Development of point-of-care biosensors for COVID-19. Frontiers in Chemistry 2020; 8: 517. https://doi.org/10.3389/fchem.2020.00517
10. Pirouz B, Arcuri N, Pirouz B, et al. Development of an assessment method for evaluation of sustainable factories. Sustainability. 2020; 12(5): 1841. https://doi.org/10.3390/su12051841
11. Saudagar RB, Kanchan TM. A review on gold nanoparticles. Asian J. Pharm. Res. 2016 Jan;6(1):45-8.
12. Khan Y, Gupta P, Bihari B, Sharma VK, Aziz I. A Review-Miracle of Nanotechnology in Cosmetics. Research Journal of Topical and Cosmetic Sciences. 2014;5(1):15-22.
13. Sharma S, Kundu A, Basu S, et al. Indians vs. COVID-19: The scenario of mental health. Sensors International. 2020; 1: 100038.https://doi.org/10.1016/j.sintl.2020.100038
14. Borse V, Konwar AN, Buragohain P. Oral cancer diagnosis and perspectives in India. Sensors International. 2020; 1: 100046. https://doi.org/10.1016/j.sintl.2020.100046
15. R&D Blueprint and COVID-19. World Health Organization. 2020. http://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus/en/. Accessed 13 March 2020.
16. Arabi YM, Asiri AY, Assiri AM, et al. Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial. Trials. 2020;21(1):1-8. https://doi.org/10.1186/s13063-019-3846-x
17. Tian S, Hu W, Niu L, et al. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer. 2020; 15(5): 700–704. https://doi.org/10.1016/j.jtho.2020.02.010
18. Ghosh S, Bomma S, Prasanna VL, Srivani P, Bhanji D. New Analytical Methods in Nanotechnology-A Review. Asian Journal of Research in Pharmaceutical Science. 2013;3(1):31-41.
19. Rangayasami A, Kannan K, Murugesan S, et al. Influence of nanotechnology to combat against COVID-19 for global health emergency: A review. Sensors International. 2021; 2: 100079. https://doi.org/10.1016/j.sintl.2020.100079
20. Sivasankarapillai VS, Pillai AM, Rahdar A, et al. On Facing the SARS-CoV-2 (COVID-19) with Combination of Nanomaterials and Medicine: Possible Strategies and First Challenges. Nanomaterials. 2020; 10(5): 852. https://doi.org/10.3390/nano10050852
21. Carvalho APA, Conte‐Junior CA. Recent advances on nanomaterials to COVID‐19 management: a systematic review on antiviral/virucidal agents and mechanisms of SARS‐CoV‐2 inhibition/inactivation. Global Challenges. 2021; 5(5): 2000115. https://doi.org/10.1002/gch2.202000115
22. Nikam A, Patil A, Magdum C. Overview and its application. Asian Journal of Pharmacy and Technology. 2021 Dec 1;11(4).
23. Khurana A, Allawadhi P, Khurana I, et al. Role of nanotechnology behind the success of mRNA vaccines for COVID-19. Nano Today. 2021; 38: 101142.
24. Abdelhamid HN, Badr G. Nanobiotechnology as a platform for the diagnosis of COVID-19: a review. Nanotechnology for Environmental Engineering. 2021; 6(1): 1-26. https://doi.org/10.1007/s41204-021-00109-0
25. Bhalla N, Pan Y, Yang Z, et al. Opportunities and challenges for biosensors and nanoscale analytical tools for pandemics: COVID-19. ACS Nano. 2020; 14(7): 7783-7807. https://doi.org/10.1021/acsnano.0c04421
26. Srivastava M, Srivastava N, Mishra PK, et al. Prospects of nanomaterials-enabled biosensors for COVID-19 detection. Science of The Total Environment. 2021; 754: 142363. https://doi.org/10.1016/j.scitotenv.2020.142363
27. Milane L, Amiji M. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine. Drug Delivery and Translational Research. 2021; 11(4): 1309-1315.
28. Bhattacharjee S, Joshi R, Chughtai AA, et al. Graphene modified multifunctional personal protective clothing. Advanced Materials Interfaces. 2019; 6(21): 1900622. https://doi.org/10.1002/admi.201900622
29. Chaudhary V, Royal A, Chavali M, et al. Advancements in research and development to combat COVID-19 using nanotechnology. Nanotechnology for Environmental Engineering. 2021; 6(1): 1-15. https://doi.org/10.1007/s41204-021-00102-7
30. Talebian S, Wallace GG, Schroeder A, et al. Nanotechnology-based disinfectants and sensors for SARS-CoV-2. Nature Nanotechnology. 2020; 15(8): 618-621. https://doi.org/10.1038/s41565-020-0751-0
31. Aydemir D, Ulusu NN. Correspondence: Angiotensin-converting enzyme 2 coated nanoparticles containing respiratory masks, chewing gums and nasal filters may be used for protection against COVID-19 infection. Travel Medicine and Infectious Disease. 2020; 37: 101697. https://doi.org/10.1016/j.tmaid.2020.101697
32. Imai Y, Kuba K, Rao S, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005; 436(7047): 112–116. https://doi.org/10.1038/nature03712
33. Aydemir D, Gecili F, Özdemir N, et al. Synthesis and characterization of a triple enzyme-inorganic hybrid nanoflower (TrpE@ihNF) as a combination of three pancreatic digestive enzymes amylase, protease and lipase. Journal of Bioscience and Bioengineering. 2020; 129(6): 679–686. https://doi.org/10.1016/j.jbiosc.2020.01.008
34. Shirvanimoghaddam K, Akbari MK, Yadav R, et al. Fight against COVID-19: The case of antiviral surfaces. APL Materials. 2021; 9(3): 031112. https://doi.org/10.1063/5.0043009
35. Erkoc P, Ulucan-Karnak F. Nanotechnology-Based Antimicrobial and Antiviral Surface Coating Strategies. Prosthesis. 2021; 3(1): 25–52. https://doi.org/10.3390/prosthesis3010005
36. Ahmad S, Zamry AA, Tan HTT, et al. Targeting dendritic cells through gold nanoparticles: A review on the cellular uptake and subsequent immunological properties. Molecular Immunology. 2017; 91: 123–133. https://doi.org/10.1016/j.molimm.2017.09.001
37. Hofmann H, Hattermann K, Marzi A, et al. S Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Mediates Entry into Hepatoma Cell Lines and Is Targeted by Neutralizing Antibodies in Infected Patients. Journal of Virology. 2004; 78(12): 6134–6142. https://doi.org/10.1128/jvi.78.12.6134-6142.2004
38. Kim YS, Son A, Kim J, et al. Chaperna-mediated assembly of ferritin-based Middle East respiratory syndrome-coronavirus nanoparticles. Frontiers in Immunology. 2018; 9: 1093.https://doi.org/10.3389/fimmu.2018.01093
39. Jung S-Y, Kang KW, Lee E-Y, et al. Heterologous prime–boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus. Vaccine. 2018; 36(24): 3468–3476. https://doi.org/10.1016/j.vaccine.2018.04.082
40. Shan B, Broza YY, Li W, et al. Multiplexed Nanomaterial-Based Sensor Array for Detection of COVID-19 in Exhaled Breath. ACS Nano. 2020; 14(9): 12125-12132.https://doi.org/10.1021/acsnano.0c05657
41. Kumar R, Jha AK, Jain SK. Nanomedicine: An Emerging Area of Nanotechnology. Research Journal of Pharmaceutical Dosage Forms and Technology. 2009;1(1):18-21.
42. Asif M, Ajmal M, Ashraf G, et al. The role of biosensors in coronavirus disease-2019 outbreak. Current Opinion in Electrochemistry. 2020; 23: 174–184. https://doi.org/10.1016/j.coelec.2020.08.011
43. Seo G, Lee G, Kim MJ, et al. Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor. ACS Nano. 2020; 14(4): 5135–5142. https://doi.org/10.1021/acsnano.0c02823
44. Kerry RG, Malik S, Redda YT, et al. Nano-based approach to combat emerging viral (NIPAH virus) infection. Nanomedicine: Nanotechnology, Biology and Medicine. 2019; 18: 196–220. https://doi.org/10.1016/j.nano.2019.03.004
45. Shi X, Sun K, Baker JR. Spontaneous Formation of Functionalized Dendrimer-Stabilized Gold Nanoparticles. The Journal of Physical Chemistry C. 2008; 112(22): 8251–8258. https://doi.org/10.1021/jp801293a
46. Fung SY, Yuen KS, Ye ZW, et al. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerging Microbes & Infections. 2020; 9(1), 558-570.https://doi.org/10.1080/22221751.2020.1736644
47. Akbari A, Rezaie J. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia. Stem Cell Research & Therapy. 2020; 11(1): 1-10.
48. Behbudi G. Effect of silver nanoparticles disinfectant on covid-19. Advances in Applied NanoBio-Technologies. 2021; 2(2): 63-67.
49. Ghaffari H, Tavakoli A, Moradi A, et al. Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine. Journal of Biomedical Science. 2019; 26(1): 1-10. https://doi.org/10.1186/s12929-019-0563-4
50. Loutfy SA, Elberry MH, Farroh KY, et al. Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines. International Journal of Nanomedicine. 2020; 15: 2699–2715. https://doi.org/10.2147/ijn.s241702
51. Khurana A, Tekula S, Godugu C. Nanoceria suppresses multiple low doses of streptozotocin-induced Type 1 diabetes by inhibition of Nrf2/NF-κB pathway and reduction of apoptosis. Nanomedicine. 2018; 13(15): 1905–1922. https://doi.org/10.2217/nnm-2018-0085
52. Campos EVR, Pereira AES, de Oliveira JL, et al. How can nanotechnology help to combat COVID-19? Opportunities and urgent need. Journal of Nanobiotechnology. 2020; 18(1): 1-23. https://doi.org/10.1186/s12951-020-00685-4